Procymate
![]() | |
| Clinical data | |
|---|---|
| Routes of administration | oral |
| ATC code | none |
| Identifiers | |
| |
| CAS Number |
13931-64-1 |
| PubChem (CID) | 3050432 |
| ChemSpider |
2312494 |
| UNII |
308EUN932K |
| ChEMBL |
CHEMBL2104652 |
| Chemical and physical data | |
| Formula | C10H19O2 |
| Molar mass | 185.263 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| | |
Procymate (Equipax) is a carbamate derivative which is a sedative and anxiolytic drug. It was previously manufactured and marketed in Belgium. The usual dose for adults is 800 to 1200 mg per day.[1] Procymate shares a similar structure and mechanism of action with the related drugs hexapropymate and phenprobamate.
References
- ↑ "Procymate," Bank of Automated Data on Drugs. VIDAL Drug Database. <http://www.biam2.org/www/Sub394.html>
| Alcohols | |
|---|---|
| Barbiturates |
|
| Benzodiazepines |
|
| Carbamates | |
| Flavonoids | |
| Imidazoles | |
| Kava constituents |
|
| Monoureides |
|
| Neuroactive steroids |
|
| Nonbenzodiazepines |
|
| Phenols | |
| Piperidinediones | |
| Pyrazolopyridines | |
| Quinazolinones | |
| Volatiles/gases |
|
| Others/unsorted |
|
See also: GABAergics | |
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
